Fresenius SE & Co. KGaA - Asset Resilience Ratio
Fresenius SE & Co. KGaA (FRE) has an Asset Resilience Ratio of 9.40% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Fresenius SE & Co. KGaA working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2012–2024)
This chart shows how Fresenius SE & Co. KGaA's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Fresenius SE & Co. KGaA total assets.
Liquid Assets Composition Over Time
This chart breaks down Fresenius SE & Co. KGaA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Fresenius SE & Co. KGaA to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €2.36 Billion | 5.57% |
| Short-term Investments | €1.63 Billion | 3.84% |
| Total Liquid Assets | €3.99 Billion | 9.40% |
Asset Resilience Insights
- Limited Liquidity: Fresenius SE & Co. KGaA maintains only 9.40% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Fresenius SE & Co. KGaA Industry Peers by Asset Resilience Ratio
Compare Fresenius SE & Co. KGaA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Aier Eye Hospital Group
SHE:300015 |
Medical Care Facilities | 3.43% |
|
Extendicare Inc
TO:EXE |
Medical Care Facilities | 32.62% |
|
MLP Saglik Hizmetleri AS
IS:MPARK |
Medical Care Facilities | 0.99% |
|
Vibhavadi Medical Center Public Company Limited
BK:VIBHA |
Medical Care Facilities | 4.19% |
|
Lippo Karawaci Tbk
JK:LPKR |
Medical Care Facilities | 0.51% |
|
Pacific Smiles Group Ltd
AU:PSQ |
Medical Care Facilities | 10.35% |
|
Aikchol Hospital Public Company Limited
BK:AHC |
Medical Care Facilities | 45.54% |
|
Golden House
TA:GOHO |
Medical Care Facilities | 20.16% |
Annual Asset Resilience Ratio for Fresenius SE & Co. KGaA (2012–2024)
The table below shows the annual Asset Resilience Ratio data for Fresenius SE & Co. KGaA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.02% | €8.00 Million ≈ $9.35 Million |
€43.55 Billion ≈ $50.91 Billion |
0.00pp |
| 2023-12-31 | 0.02% | €9.00 Million ≈ $10.52 Million |
€45.28 Billion ≈ $52.94 Billion |
-0.95pp |
| 2022-12-31 | 0.97% | €744.00 Million ≈ $869.81 Million |
€76.42 Billion ≈ $89.34 Billion |
-0.51pp |
| 2021-12-31 | 1.48% | €1.07 Billion ≈ $1.25 Billion |
€71.96 Billion ≈ $84.13 Billion |
+0.27pp |
| 2020-12-31 | 1.21% | €806.00 Million ≈ $942.30 Million |
€66.65 Billion ≈ $77.92 Billion |
+0.27pp |
| 2019-12-31 | 0.94% | €629.00 Million ≈ $735.37 Million |
€67.01 Billion ≈ $78.34 Billion |
-1.77pp |
| 2018-12-31 | 2.71% | €1.54 Billion ≈ $1.80 Billion |
€56.70 Billion ≈ $66.29 Billion |
+1.76pp |
| 2017-12-31 | 0.95% | €506.00 Million ≈ $591.57 Million |
€53.13 Billion ≈ $62.12 Billion |
+0.24pp |
| 2016-12-31 | 0.72% | €333.00 Million ≈ $389.31 Million |
€46.45 Billion ≈ $54.30 Billion |
+0.11pp |
| 2015-12-31 | 0.61% | €263.00 Million ≈ $307.47 Million |
€43.17 Billion ≈ $50.47 Billion |
+0.23pp |
| 2014-12-31 | 0.38% | €152.00 Million ≈ $177.70 Million |
€39.90 Billion ≈ $46.64 Billion |
+0.25pp |
| 2013-12-31 | 0.13% | €43.00 Million ≈ $50.27 Million |
€32.76 Billion ≈ $38.30 Billion |
-0.09pp |
| 2012-12-31 | 0.22% | €68.00 Million ≈ $79.50 Million |
€30.66 Billion ≈ $35.85 Billion |
-- |
About Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machin… Read more